chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The day after the patient received the vaccine she developed generalized body weakness, could not go to the bathroom by herself, became nauseated and vomited some.  On the day of presentation to the ED, her husband could not get her out of bed and she was unresponsive through the entire day so he called an ambulance.  On presentation to the ED around 6 pm she was moribund, unresponsive, hypoxic and hypotensive.  Her temperature in the ED was 103.4F.  Patient was admitted with a diagnosis of septic shock secondary to UTI or pneumonia, acute hypoxic respiratory failure requiring mechanical ventilation, acute encephalopathy, NSTEMI and acute kidney injury.  Patient was intubated and pressors were antibiotics were started.  Within the next few days, the physicians began to suspect cardiogenic shock as pressors were discontinued and patient was stable on dobutamine alone.  SvO2 from central line improved from 53.7% to 83.4$ after dobutamine was started.  Echocardiogram showed an ejection fraction of 30-40% compared to 55-65% in 2019.  This lead the team to suspect the cardiogenic shock may have been caused by myocarditis from the COVID vaccine.  Patient is also experiencing an increase in liver function tests thought to either be shock liver or rejection of her transplant.  Patient's status has improved, however, she remains confused.  The neurologist feels she has encephalopathy secondary to multiple comorbidities and some degree of critical illness delirium.  Patient is still in the hospital.
On the morning after receiving vaccine, experienced injection-site arm pain. Later this same day, experience severe fatigue and bilateral leg pain which made it difficult to ambulate. On Nov. 13, 2021, developed a non-productive cough that lasted 3 1/2 weeks.  Fatigue and lower body pain and imbalance continued for 3 days.  I was unable to accomplish any of my activities of daily living. I did have nausea for 2 days after receiving vaccine (no emesis). No symptoms of fever or chills were noted during this time. I self-administered OTC analgesics and cough decongestion.  For the 1st vaccine dose-no symptoms whatsoever. On the 2nd vaccine dose- developed severe injection-site arm pain-lasting 1/2  a day.
Developed left-sided tinnitus 3 days after vaccine given.  Getting louder.  Mild pain in left breast.
Immunized at 1730 on 10/21/22.  By Saturday morning 10/22/22 at 0600, severe myalgias (head to toe), fever 100.3 to 100.5, rigors, nausea/diarrhea, dizziness, weakness. Ibuprofen throughout Saturday helped slightly with fever and myalgias. Starting Sunday 10/23/22, also experiencing wheezing and shortness of breath, both manageable with albuterol inhaler. Starting Monday 10/24/22, No fever or chills,  shortness of breath and wheezing better but still short of breath if talking,  still very weak and dizzy.  Not able to perform normal daily work, three days of work missed, anticipating it will likely be four days total.
Just before administering the HPV I administered the Fluzone flu shot to the right deltoid. Patient had no complications and tolerated the shot well. I administered the HPV to the left deltoid. Mid-injection patient began to have a tonic clonic seizure. He was not responsive to verbal commands, and I had to hold patient up in the chair so he wouldn't fall out. Patient finally came around after seizing for 30 seconds. He became pale, diaphoretic, He was hot for a second & then cold, He was lethargic, and leaning on his mother. EMS arrives after being called by another staff member. He was Ox3, but very slow to answer. Patients eyes were dilated. He can't remember the events that led to this issue. He leaves with EMS, and mother leaves to meet them at hospital.
Severe Psoriatic arthritis flare, red swollen, painful joints, hands and feet.
GUILLAIN-BARRE SYNDROME; This spontaneous report received from a consumer via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown.  The Company is unable to perform follow-up to request batch number) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date, the patient experienced Guillain-Barre syndrome. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of Guillain-Barre syndrome was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: This spontaneous report received from a consumer via a company representative concerned a female of unspecified age who experienced Guillain Barre syndrome (GBS) an unknown time after vaccine. Medical history and concomitant medications were not reported. On an unspecified date, the patient experienced GBS. No other details regarding symptoms, diagnostics, treatment, or outcome were provided. Information is limited in this case, and the occurrence of GBS could represent background incidence of such events in the general population. Therefore, the relationship of GBS to vaccination is considered unclassifiable due to insufficient information. Additional information will be requested if contact information becomes available.
Hospitalized with STROKE to Right side of brain, loss of grip & sensation to left hand/fingers, headache, visual changes, double vision, bizarre "floaters" as signs/symptoms.   TX: DC Eliquist, Discharged to Home with Enoxaprin Sodium Injectable 100mg BID x5 weeks, Heart Monitor, follow up ultrasound to Left leg, follow up visit to PCP   Patient slowly recovering gross & fine motor movement to Left hand/fingers, Additional blood test results awaited.
Seizures (Grand Mal, Myoclonic, Febrile )that continued for 3 years.  Still has febrile seizures.
pt recvd vax 29SEP95 & 3 days following vax pt devel varicella-like rash w/itching;MD noted that the rash appeared suddenly & disappeared almost overnoc;MD described the rash as pruritic papular/small urticaria, almost vesicular w/rosy base
According to the patient after receiving the Moderna vaccine she experienced sharp pain coming from the lungs and through her body.. the pain lasted few minutes and went  away. It happened about 3 to 4 times  few days apart. The patient did not get second dose
Abdominal pain (R) lower, (L) arm numbness. 10/27/08-records received-office visit 1/15/08-C/O stomach ache times 2 days with nausea. Abdomen tender. 3/28/08-no complaints. 10/14/08-left wrist numbness, neuro exam normal.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 07May2022 as dose number unknown, single (Batch/Lot number: unknown) at the age of 68 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Treated high blood pressure" (unspecified if ongoing); "Bradycardia" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown Result. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinal course: No Known allergies reported. Anti-viral details: product- COVID 19 Treatment, treatment start date-27Jun2022, treatment stop date-01Jul2022, indication-Treatment of COVID-19.  The information on the batch/lot number for [BNT162B2] has been requested and will be submitted if and when received.
Immediately after pt got hep A and INFLUENZA vaccine, he developed hives at his face, neck, trunk, and a papular rash at injection site.
Pt received PREVNAR 13 on 10/12/15. Within a few days he had to seek treatment for severe pain. Patient states he has limited mobility on his arm. Per MD office xray shows bone spurring and MD does not feel related to shot.
sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (sick). At the time of the report, ILLNESS (sick) outcome was unknown.            No concomitant medications were provided by the reporter. No treatment information was provided by the reporter.   This case was linked to MOD-2021-408707, MOD-2021-409000 (Patient Link).
This spontaneous report as received from a consumer refers to a 69 year old male patient concerning himself with no pertinent medical history/concurrent conditions. On 13-OCT-2014, the patient was vaccinated with a dose of ZOSTAVAX (lot number, route and expiration date were not reported). No concomitant medication reported. On 13-OCT-2014, the patient experienced headache, body aches and injection site discomfort. On 15-OCT-2014, about two days after receiving the injection, the patient experienced real bad chills, muscle cramps, body aches and shaked in a ball position for 30 seconds. On an unknown date in 2014, the patient developed a rash under his arm and a bladder infection. The patient also reported that he is now experiencing pain in the balls of his feet and when he "nods his head he gets a vibration of tingling feeling in the base of his neck that runs down to the base of his spine sometimes, and other times it runs down to his left leg and to his foot". The patient reported that after visiting the doctor for the adverse effects, his doctor told him that the shingles anti-virus is not in his system. The patient reported that the vaccine had failed. The outcome of headache, bladder infection, rash under arm, muscle cramps, shaking in a ball position for 30 seconds, chills real bad, body aches and injection site discomfort was reported as "eventually went away", recovered. The outcome of pain in the balls of his feet and when he "nods his head he gets a vibration of tingling feeling in the base of his neck that runs down to the base of his spine sometimes, and other times it runs down to his left leg and to his foot" was reported as not recovered. Additional information has been requested.
This case was reported by a physician, via a GSK representative and described the occurrence of lips white in a 10-year-old male subject who was vaccinated with BOOSTRIX (GlaxoSmithKline). Concurrent medical conditions included nervousness prior to receiving the vaccination. On 17 July 2009 the subject received unspecified dose of BOOSTRIX (details unknown). On 17 July 2009, immediately after vaccination with BOOSTRIX, the subject experienced lips white, low blood pressure (63/36), pulse lower (66) and seeing white spots before eyes. On 17 July 2009, the events were resolved. Within 4 minutes after vaccination, the subject's blood pressure stabilized to 95/57 and his pulse increased to 108. The physician considered the events were unrelated to vaccination with BOOSTRIX, and that it was a vagal  response.
Pt came back to clinic after 15 min c/o tightness in her chest, she had audible wheezing. She was treated with 50mg BENADRYL (IM), albuterol via Neb, and 125mg SOLU-MEDROL IM.
Chest Heart Burning beginning 5 minutes after injection  and continuing for approximately 30 minutes Lightheadedness/dizziness beginning 15 minutes after injection and continuing intermittently for approximately 20 minutes Slight headache at left lower side base of skull.  Currently, the dizziness has subsided. Heart burning sensation has alleviated and gone to none and then back to warm but not burning.  headache slight still as of 5:15pm
sores; few white dots on my tongue; left arm painful; This spontaneous case was reported by a consumer and describes the occurrence of STOMATITIS (sores), TONGUE DISORDER, and PAIN IN EXTREMITY (left arm painful) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Jan-2021, the patient experienced STOMATITIS (sores), TONGUE DISORDER, and PAIN IN EXTREMITY (left arm painful). On 07-Jan-2021, STOMATITIS (sores), TONGUE DISORDER, and PAIN IN EXTREMITY (left arm painful) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. She reports rinsing mouth with warm water and salt. She applied Abreva on the outer part of her lip. She rinsed with Listerine.   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: Follow up was received on 20 may 2021  significant case included event start and stop date added and second dose taken. No further follow up; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
"Cold sore on lower lip within 48 hours of injection." Upper chest pain waking pt. @ 0300 1 wk after injection. No cause or change of routine other than Zoster vaccination one wk prior. Cardiologist discharged with dx. possible pleurisy.5/26/09-records received for DOS 4/22-4/24/09-presented to ED with C/O CP, awoke with chest pressure, felt weak. Shortness of breath. ICD-9 786.59 chest pain.
vial was initially stored in the refrigerator on 02-Jun-2022 and administered on 02-Aug-2022; No adverse event; patient received moderna covid-19 vaccine past the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received moderna covid-19 vaccine past the 30 day beyond use date), PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 02-Jun-2022 and administered on 02-Aug-2022) and NO ADVERSE EVENT (No adverse event) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A22A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Pfizer Covid-19 vaccine (Primary series), Pfizer Covid-19 vaccine (first booster dose) and Pfizer Covid-19 vaccine (Primary series). Past adverse reactions to the above products included No adverse event with Pfizer Covid-19 vaccine, Pfizer Covid-19 vaccine and Pfizer Covid-19 vaccine.    On 02-Aug-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Aug-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received moderna covid-19 vaccine past the 30 day beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 02-Jun-2022 and administered on 02-Aug-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient received moderna covid-19 vaccine past the 30 day beyond use date), PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 02-Jun-2022 and administered on 02-Aug-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (patient received moderna covid-19 vaccine past the 30 day beyond use date) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 02-Jun-2022 and administered on 02-Aug-2022).    No concomitant medications information was reported.   The vial was initially stored in the refrigerator on 2-Jun-2022.  Not the pharmacist aware of vial was undergo any temperature excursions. . It was reported that there were no known adverse events.  No treatment medications were provided.   This case was linked to MOD-2022-629202, MOD-2022-629210 (Patient Link).
10 hours since second vaccination I had muscle aches, chills, myalgia, nausea, headache, and fatigue. This went on for.36-48 hrs. After flu like symptoms subsided,I started to get pins and needles in both feet, legs, and hands. Then twitching and muscle spasms in my legs.
Severe daily headaches for over 6 months and now I still have about 3-4 headaches a week, varying in severity. I have also had diarrhea almost daily since this injection. My stools have NEVER been normal since the day after receiving the Moderna covid-19 vaccine I primary spoke to the doctor at the suboxone clinic about this. I can't remember his name but he prescribed me a headache medicine to try to help with this and stated a lot of people were reporting headaches after covid 19 injection. The suboxone clinic info where this male doctor works is OARS (opiate abuse recovery services) I'm reporting these issues now because it's been just about a year since I received the vaccine and I'm STILL having these side effects. I did report the issue to Dr., twice, at primary health network but he didn't even acknowledge my concerns either time. One of their medical assistants spoke with me about the injection, acknowledging my concerns, so it should be at least reported by her in their system. This was my 2nd time reporting and was the last time I was in their office. About 3-4 mo ago, maybe in may?
Initial report received on 21-Nov-2005 from a health care professional in USA. A 51 year old male patient, who is a physician with a medical history of no known allergies and discoid lupus erythematosus developed urticaria on abdomen, arms, occipital scalp and sacrum approximately 2 days following the influenza vaccine (Fluzone SV 2005-2006) lot no:U1817AA in the right deltoid on 09-Nov-2005. He was also complained of digital swelling of toes and heels and also heel pain. He self diagnosed with "Reiters syndrome:, self medicated since an unspecified time with zithromax, cipro and doxycycline but no steroids. The CBC, CMP, sedimentation rate, C-reactive protein and HIV negative at an unspecified time. he had not seen any of note that he was receiving Fluzone annually and concomitantly taking plaquenil since an unspecified time.
Ringing in ears. Tinnitus. Intermittent ringing in ears, chirping, cricket sounds in left ear.
Patient came in for a wellness visit with Dr. on 4/20/23. She ordered the patient a DTaP (#3) and an IPV (#2) but was administered Kinrix. GSK was called for advisement and the patients mother was notified. Dr. let the patients mother know of what signs and symptoms to look out for. Dr. spoke again with patients mother 4/24/23 to follow up and he is not experiencing any adverse reaction.
Patients first dose of Pfizer Monovalent (5y-11y) was administered 01/25/2023. Patient came in the office 03/15/2023 to receive 2nd dose of Pfizer Monovalent (5y-11y). Patient received 0.2mL of Pfizer Monovalent (6m-4y) by a vaccine overlook error. Per CDC & Pfizer Guideline recommendation, a repeat dose of Pfizer Monovalent (5y-11y) will be administered immediately. After this vaccine is given, administration of a booster can occur at the regular recommended schedule.  PCP & patient aware. No known adverse effects at this time.
Patient began to "feel weird" during 15 minute monitoring time after receiving vaccine (reported this at 3:20pm). Provider obtained patient's vital signs and continued to monitor patient with no other complaints until 3:40pm. At that time patient reported her top lip "felt tingly" and became anxious. Patient's blood pressure began to drop and provider administered epi at 3:58pm. EMS was onsite already and transported patient to ER at 4pm.
A pt with a history of varicella exposure was vaccinated with varicella virus vaccine live on 09/20/1999. On 10/06/1999 the pt experienced greater than 100 vesicles, some of which were located in his mouth and ears. Additionally pt had a fever greater than 101F for 3-4 days. On 11/14/1999 the pt recovered. the pts siblings had similar experiences following exposure to varicella virus vaccine live.
She was cleaned out, pretty much cleaned out of her bowels, but she kept getting pains and started passing blood clots; She kept getting pains; Bad stomach cramps; Diarrhea; This is a spontaneous report from a contactable consumer. An 81-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL0142, expiration date unknown), via an unspecified route of administration, on 14Dec2020 10:00 at a single dose for COVID-19 immunization. Medical history included hypertension from an unknown date. Concomitant medication included atorvastatin, losartan, alprazolam, mirtazapine, and several medications because of her age and she has hypertension. The patient had her vaccine on 14Dec2020 at about 10 o'clock and a couple of hours later she began getting really bad stomach cramps and had diarrhea for most of the day and about 11 o'clock of 14Dec2020 she reported she was cleaned out, pretty much cleaned out of her bowels, but she kept getting pains and started passing blood clots. Treatment for the events include Some Pepto-Bismol (as reported). The outcome of the event "bad stomach cramps" was not recovered, and for other events was unknown.
A week after receiving the vaccine, I woke up with my arm red, swollen, and itchy around the injection site. The swelling is about 3-4 inches in diameter.
Face puffy. Eyes swollen. No swelling of the mouth tongue or throat. No difficulty breathing. Taking Benadryl 25mg every 6 hours. Monitoring for signs of hives swelling and difficulty breathing.
Personage Turner Syndrome e salt my in a paralysis of right hand/Brachial Plexitis; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 76-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 01Oct2021 at 12:15 as dose 3 (booster), single (Lot number: FF2590) at the age of 75 years, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: FLUOXETINE. Vaccination history included: BNT162b2 (Dose Number: 2, Batch/Lot No: EL9266, Location of injection: Arm Left, Vaccine Administration Time: 11:45 AM), administration date: 23Feb2021, when the patient was 75-year-old, for Covid-19 immunization; BNT162b2 (Dose Number: 1, Batch/Lot No: EL9261, Location of injection: Arm Left, Vaccine Administration Time: 11:00 AM), administration date: 02Feb2021, when the patient was 75-year-old, for Covid-19 immunization.  The following information was reported: NEURALGIC AMYOTROPHY (disability) with onset 26Nov2021, outcome "not recovered", described as "Personage Turner Syndrome e salt my in a paralysis of right hand/Brachial Plexitis". The event "personage turner syndrome e salt my in a paralysis of right hand/brachial plexitis" required emergency room visit. Therapeutic measures were taken as a result of neuralgic amyotrophy. Patient did not receive any other vaccines in 4 weeks. Chiropractor provided some pain relief. No covid prior vaccination and Not tested covid post vaccination. No Known allergies.
I am describing side effects experienced by me.   I had nausea, sore arm, headaches.  None of these effects are normal for me.  I have also had shingles twice (small outbreaks caught early) and had chicken pox as a child.